If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Paul Yeh is a consultant haematologist and clinician-scientist with dual appointments at Monash Health and Monash University.  He is the Head of the Blood Cancer Biomarkers Laboratory in the School of Clinical Sciences at Monash Health. His laboratory’s research interest is in the use of blood based molecular biomarkers to understand normal and malignant haematopoiesis. The aim of the research is to translate novel biomarker discoveries from the bench into clinical practice to improve outcomes in patients with haematological malignancies.

Dr Yeh has been the finalist of the Victorian Premier’s Awards for Health and Medical Research (Clinical Researcher) and a recipient of the EHA/ASH translational research in Haematology (TRTH) scholar award. He is currently a recipient of a NHMRC/MRFF Emerging Leadership Fellow Grant.

His clinical interest is in molecular haematology and myeloid neoplasms where he is a consultant haematopathologist in the molecular pathology department and the clinical lead for myeloproliferative neoplasms at Monash Health.

 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Medicine, PhD, Molecular monitoring and screening in haematological malignancies, University of Melbourne

Award Date: 7 Nov 2018

Bachelor of Medicine, Bachelor of Surgery, MBBS, University of Melbourne

Award Date: 3 Dec 2005

Bachelor of Medical Science, BMedSci

Award Date: 3 Dec 2005

Research area keywords

  • Haematology
  • haematological malignancies
  • clonal haematopoiesis
  • Myeloid leukaemia
  • Myeloproliferative Diseases
  • Genomics & Transcriptomics
  • Next Generation Sequencing
  • circulating tumour DNA
  • Whole genome sequencing
  • bioinformatics
  • Multi-omics
  • Biomarkers
  • Lymphoid Malignancies